世界の樹状細胞がんワクチン市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP10862)
◆英語タイトル:Global Dendritic Cell Cancer Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP10862
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:136
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、樹状細胞がんワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。樹状細胞がんワクチンの種類別市場規模(クレアバクス、シプリューセル-T(プロベンジ)、その他)、用途別市場規模(幼児、成人)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Medigene、DCPrime、Batavia Bioservices、Activarti、DanDrit Biotech、Argos Therapeutics、Elios Therapeutics、Creagene、Bellicum Pharmaceuticals、Sanpower (Dendreon)、Glaxo Smith Kline、Vaxil Bio、Immunicum、ImmunoCellular、Northwest Biotherapeutics、Kiromic、Medigene、Tella、Merck
・地域別グローバル市場分析 2015年-2020年
・樹状細胞がんワクチンの北米市場(アメリカ、カナダ、メキシコ)
・樹状細胞がんワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・樹状細胞がんワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・樹状細胞がんワクチンの南米市場(ブラジル、アルゼンチン)
・樹状細胞がんワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:クレアバクス、シプリューセル-T(プロベンジ)、その他
・用途別分析:幼児、成人
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Dendritic Cell Cancer Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Dendritic Cell Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Dendritic Cell Cancer Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Dendritic Cell Cancer Vaccine market has been segmented into
CreaVax
Sipuleucel-T (Provenge)
Others

By Application, Dendritic Cell Cancer Vaccine has been segmented into:
Pediatrics
Adults

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dendritic Cell Cancer Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Dendritic Cell Cancer Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dendritic Cell Cancer Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Dendritic Cell Cancer Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Dendritic Cell Cancer Vaccine Market Share Analysis
Dendritic Cell Cancer Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dendritic Cell Cancer Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dendritic Cell Cancer Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Dendritic Cell Cancer Vaccine are:
Medigene
DCPrime
Batavia Bioservices
Activarti
DanDrit Biotech
Argos Therapeutics
Elios Therapeutics
Creagene
Bellicum Pharmaceuticals
Sanpower (Dendreon)
Glaxo Smith Kline
Vaxil Bio
Immunicum
ImmunoCellular
Northwest Biotherapeutics
Kiromic
Medigene
Tella
Merck

Among other players domestic and global, Dendritic Cell Cancer Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dendritic Cell Cancer Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dendritic Cell Cancer Vaccine, with price, sales, revenue and global market share of Dendritic Cell Cancer Vaccine in 2018 and 2019.
Chapter 3, the Dendritic Cell Cancer Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dendritic Cell Cancer Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dendritic Cell Cancer Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dendritic Cell Cancer Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Dendritic Cell Cancer Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dendritic Cell Cancer Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 CreaVax
1.2.3 Sipuleucel-T (Provenge)
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dendritic Cell Cancer Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pediatrics
1.3.3 Adults
1.4 Overview of Global Dendritic Cell Cancer Vaccine Market
1.4.1 Global Dendritic Cell Cancer Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medigene
2.1.1 Medigene Details
2.1.2 Medigene Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medigene SWOT Analysis
2.1.4 Medigene Product and Services
2.1.5 Medigene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 DCPrime
2.2.1 DCPrime Details
2.2.2 DCPrime Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 DCPrime SWOT Analysis
2.2.4 DCPrime Product and Services
2.2.5 DCPrime Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Batavia Bioservices
2.3.1 Batavia Bioservices Details
2.3.2 Batavia Bioservices Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Batavia Bioservices SWOT Analysis
2.3.4 Batavia Bioservices Product and Services
2.3.5 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Activarti
2.4.1 Activarti Details
2.4.2 Activarti Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Activarti SWOT Analysis
2.4.4 Activarti Product and Services
2.4.5 Activarti Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 DanDrit Biotech
2.5.1 DanDrit Biotech Details
2.5.2 DanDrit Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 DanDrit Biotech SWOT Analysis
2.5.4 DanDrit Biotech Product and Services
2.5.5 DanDrit Biotech Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Argos Therapeutics SWOT Analysis
2.6.4 Argos Therapeutics Product and Services
2.6.5 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Elios Therapeutics
2.7.1 Elios Therapeutics Details
2.7.2 Elios Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Elios Therapeutics SWOT Analysis
2.7.4 Elios Therapeutics Product and Services
2.7.5 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Creagene
2.8.1 Creagene Details
2.8.2 Creagene Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Creagene SWOT Analysis
2.8.4 Creagene Product and Services
2.8.5 Creagene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bellicum Pharmaceuticals
2.9.1 Bellicum Pharmaceuticals Details
2.9.2 Bellicum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bellicum Pharmaceuticals SWOT Analysis
2.9.4 Bellicum Pharmaceuticals Product and Services
2.9.5 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanpower (Dendreon)
2.10.1 Sanpower (Dendreon) Details
2.10.2 Sanpower (Dendreon) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanpower (Dendreon) SWOT Analysis
2.10.4 Sanpower (Dendreon) Product and Services
2.10.5 Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Glaxo Smith Kline
2.11.1 Glaxo Smith Kline Details
2.11.2 Glaxo Smith Kline Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Glaxo Smith Kline SWOT Analysis
2.11.4 Glaxo Smith Kline Product and Services
2.11.5 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Vaxil Bio
2.12.1 Vaxil Bio Details
2.12.2 Vaxil Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Vaxil Bio SWOT Analysis
2.12.4 Vaxil Bio Product and Services
2.12.5 Vaxil Bio Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Immunicum
2.13.1 Immunicum Details
2.13.2 Immunicum Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Immunicum SWOT Analysis
2.13.4 Immunicum Product and Services
2.13.5 Immunicum Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 ImmunoCellular
2.14.1 ImmunoCellular Details
2.14.2 ImmunoCellular Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ImmunoCellular SWOT Analysis
2.14.4 ImmunoCellular Product and Services
2.14.5 ImmunoCellular Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Northwest Biotherapeutics
2.15.1 Northwest Biotherapeutics Details
2.15.2 Northwest Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Northwest Biotherapeutics SWOT Analysis
2.15.4 Northwest Biotherapeutics Product and Services
2.15.5 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Kiromic
2.16.1 Kiromic Details
2.16.2 Kiromic Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Kiromic SWOT Analysis
2.16.4 Kiromic Product and Services
2.16.5 Kiromic Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Medigene
2.17.1 Medigene Details
2.17.2 Medigene Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Medigene SWOT Analysis
2.17.4 Medigene Product and Services
2.17.5 Medigene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Tella
2.18.1 Tella Details
2.18.2 Tella Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Tella SWOT Analysis
2.18.4 Tella Product and Services
2.18.5 Tella Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Merck
2.19.1 Merck Details
2.19.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Merck SWOT Analysis
2.19.4 Merck Product and Services
2.19.5 Merck Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dendritic Cell Cancer Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Dendritic Cell Cancer Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Dendritic Cell Cancer Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Dendritic Cell Cancer Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Dendritic Cell Cancer Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dendritic Cell Cancer Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6.4 France Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dendritic Cell Cancer Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dendritic Cell Cancer Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.5 India Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Dendritic Cell Cancer Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Dendritic Cell Cancer Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dendritic Cell Cancer Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dendritic Cell Cancer Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Dendritic Cell Cancer Vaccine Price by Type (2015-2020)
11 Global Dendritic Cell Cancer Vaccine Market Segment by Application
11.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Dendritic Cell Cancer Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dendritic Cell Cancer Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Dendritic Cell Cancer Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.2.2 Europe Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.2.4 South America Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.3 Dendritic Cell Cancer Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Dendritic Cell Cancer Vaccine Market Share Forecast by Type (2021-2025)
12.4 Dendritic Cell Cancer Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Dendritic Cell Cancer Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Medigene、DCPrime、Batavia Bioservices、Activarti、DanDrit Biotech、Argos Therapeutics、Elios Therapeutics、Creagene、Bellicum Pharmaceuticals、Sanpower (Dendreon)、Glaxo Smith Kline、Vaxil Bio、Immunicum、ImmunoCellular、Northwest Biotherapeutics、Kiromic、Medigene、Tella、Merck

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の樹状細胞がんワクチン市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Dendritic Cell Cancer Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。